logo

For the Inventor, By the Inventor

Oxford, United Kingdom

Peter David Davis

This inventor holds 20 USPTO granted patents and 1 published patent application, primarily in Vascular Damage Agents. Top assignees: Celltech Therapeutics Limited, Angiogene Pharmaceuticals Limited, Celltech R&d Limited. Active years: 1999-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter David Davis. Retrieved from https://idiyas.com/inventor/peter-david-davis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 55.0

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 922(Granted Patents)


Location History:

  • Aston Rowant, GB (1999 - 2003)
  • Oxford, GB (1999 - 2005)
  • Watlington, GB (2003 - 2007)
  • Oxfordshire, GB (2006 - 2011)

Company Filing History:

goldMedal9 out of 81 
 
Celltech Therapeutics Limited
 patents
silverMedal7 out of 10 
 
Angiogene Pharmaceuticals Limited
 patents
bronzeMedal3 out of 68 
 
Celltech R&d Limited
 patents
4. 1 out of 1,534 
 
Astrazeneca Ab
 patents

Years Active: 1999-2011

Loading Chart...
Areas of Expertise:
Benzimidazole
Vascular Damaging Agents
Protein Kinase Inhibitors
Angiogenesis
Substituted Stilbene
Colchinol Derivatives
Bicyclic Amine Derivatives
2-Pyrimidineamine
Fused Polycyclic
2-Anilinopyrimidines
5-Aminopyrazoles
Combination Therapies
20 patents (USPTO):Explore Patents
1. 7875727 - Benzimidazole vascular damaging agents (2011-01-25),
2. 7265136 - Substituted stilbene compounds with vascular damaging activity (2007-09-04),
3. 7135502 - Colchinol derivatives as vascular damaging agents (2006-11-14),
4. 7105501 - Compositions with vascular damaging activity (2006-09-12),
5. 7087627 - Combinations for the treatment of diseases involving angiogenesis (2006-08-08),
6. 7081469 - Benzimidazole vascular damaging agents (2006-07-25),
7. 7012076 - Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases (2006-03-14),
8. 6906048 - N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity (2005-06-14),
9. 6645950 - Benzimidazole vascular damaging agents (2003-11-11),
10. 6599908 - Fused polycyclic 2-aminopyrimidine derivatives (2003-07-29),
11. 6552029 - 2-pyrimidineamine derivatives and processes for their preparation (2003-04-22),
12. 6337335 - Substituted 2-anilinopyrimidines useful as protein kinase inhibitors (2002-01-08),
13. 6235746 - Substituted 2-anilinopyrimidines useful as protein kinase inhibitors (2001-05-22),
14. 6133257 - Fused polycyclic 2-aminopyrimidine derivatives (2000-10-17),
15. 6114333 - 2-Pyrimidineamine derivatives and processes for their preparation (2000-09-05),

Title: The Innovative Mind of Peter David Davis

Introduction: Peter David Davis, a brilliant inventor hailing from Oxford, GB, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Peter David Davis holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing his commitment to creating a sustainable future.

Career Highlights: With a career spanning over two decades, Peter David Davis has worked with leading tech companies to develop cutting-edge solutions that have revolutionized various industries. His expertise in machine learning and data analytics has earned him global recognition.

Collaborations: Throughout his career, Peter David Davis has collaborated with top research institutions and universities to further his research and bring his inventions to life. His collaborative spirit has led to the successful implementation of several pioneering technologies.

Conclusion: Peter David Davis stands as a beacon of innovation, consistently pushing the boundaries of what is possible in the world of technology. His passion for creating impactful solutions underscores his status as a visionary inventor in the modern era.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…